Perspectives

Navigating Multi-Indication Launches in Rare Disorders
When we were engaged, the client was seeking support to better understand the current situation in both indications, including strategic opportunities and challenges to address in launch preparations.
Case Study Dec 1, 2023
Supporting a Top-15 Biopharmaceutical Company with Strategy Development to Maintain a Leadership Position
An established pharmaceutical company with a strong immunology portfolio was looking to build consensus and alignment around a forward-looking strategy to maintain their leadership in immunology. Discover how we helped our client define an immunology strategy by prioritizing the most compelling disorder and technology platform opportunities and building alignment among cross-functional stakeholders to drive the unified strategy for the mid- to long-term.
Case Study Nov 20, 2023
Supporting a Pharma Company with Lifecycle Management Strategy
The commercial development team of an established pharma company with two late-stage trials for expansion indications of a marketed product for a rare inflammatory disease required broad support for lifecycle management (LCM) activities. Learn how we helped our understand how to utilize an established salesforce to effectively navigate additional disease areas.
Case Study Nov 13, 2023
European Perspectives of the Inflation Reduction Act
The recent ACCESS Europe 2023 Annual Meeting held in Budapest drew significant attention to the Inflation Reduction Act (IRA) from a global perspective. Read more about the policy, payer, economist, and pharmaceutical global perspectives.
View Oct 31, 2023